NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Inspira Technologies Oxy BHN Ltd (IINN) Stock Analysis

Inspira Technologies Oxy BHN Ltd (IINN) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

IINN

$1.52

+$0.79 (+109.08%)

Last trade May 26, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare IINN with… →

IINN Key Statistics

As of May 26, 2026
Trading
Open
$1.56
Previous Close
$0.73
Day's Range
1.11–1.59
52-Week Range
0.28–1.65
Volume
212.38M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.16
Valuation
Market Cap
$16.56M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
57.30
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.45
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
1-Year Return
+220.00%
Dividend and dates
Avg Volume
17.44M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

IINN Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+68.89%
2025−15.09%

As of May 26, 2026.

IINN Valuation vs Medical Devices Median

Median of 151 stocks
MetricIINNMedical Devices medianvs median
P/S ratio57.302.9819.3x the median
Profit margin0.00%−1.69%1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Inspira Technologies Oxy BHN Ltd (IINN) is capitalised at $16.56M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 34 employees.

Over the past 52 weeks the price has ranged from $0.28 to $1.65. IINN last closed at $1.52 on May 26, 2026. That is +$0.79 (+109.08%) against the previous close. The latest close sits 437.1% above that 52-week low.

Financial Health

Trailing twelve-month revenue on file is $289.00K. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −0.45.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 57.3. On price-to-sales that is 19.3 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The reported beta is 2.16. Daily returns over the trailing 1 year annualize to a volatility of 204.22%. The trailing one-year price return is +220.00%.

Growth & Income

No dividend is on file for IINN.

The record holds one complete calendar year, 2025, which returned −15.09%. So far in 2026 the price is +68.89%.

Peer Comparison

Inspira Technologies Oxy BHN Ltd (IINN) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Inspira Technologies Oxy BHN Ltd IINN $16.56M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Inspira Technologies Oxy BHN Ltd has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of May 26, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Inspira Technologies Oxy BHN Ltd

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

Visit website →